The main objective is to determine the clinical utility of non-invasive methods for measuring fibrosis in the initial assessment and follow-up of chronic hepatitis B in untreated adults.
In the absence of sufficient demonstration of this clinical utility, the diagnostic performances of these non-invasive methods will be defined, in comparison with liver biopsy
See also
HAS opinions and decisions
19/06/2014
Practice guidelines
07/05/2009
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
q67V9Y19HYcARNtn